Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

A challenge to the therapeutic nihilism of ESPAC-1.

Koshy MC, Landry JC, Cavanaugh SX, Fuller CD, Willett CG, Abrams RA, Hoffman JP, Thomas CR Jr.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):965-6. No abstract available.

PMID:
15752874
2.

[Adjuvant and additive therapy for cancer of the pancreas].

Neoptolemos JP, Raraty MG, Ghaneh P, Hickey H, Stocken DD, Dunn JA, Friess H, Büchler MW.

Chirurg. 2003 Mar;74(3):191-201. Review. German.

PMID:
12647075
3.

Chemotherapy for pancreatic cancer.

Bydder S, Spry N.

N Engl J Med. 2004 Jun 24;350(26):2713-5; author reply 2713-5. No abstract available.

PMID:
15218576
4.
5.

Unresolved issues in the management of locally advanced non-metastatic pancreas cancer.

Khoo VS, Price P.

Clin Oncol (R Coll Radiol). 2002 Aug;14(4):303-7. No abstract available.

PMID:
12206643
6.

[Multimodality therapy of operable pancreatic cancer].

Brunner T.

Strahlenther Onkol. 1999 Aug;175(8):413-4. German. No abstract available.

PMID:
10481775
7.

[Ways of improving long-term results of treatment in resectable pancreatic cancer].

Patiutko IuI, Kotel'nikov AG, Badalian KhV, Sagaĭdak IV.

Vopr Onkol. 1998;44(5):628-31. Review. Russian. No abstract available.

PMID:
9884731
8.
9.

[Change of 5-fluorouracil penetration in blood-pancreatic barrier of rats after high-dose radiotherapy].

Kang W, Zhao Y, Tao W, Cai L, Zhu Y.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2000 Oct;22(5):457-9. Chinese.

PMID:
12903428
10.

Adjuvant therapy in pancreatic cancer: a critical appraisal.

Oettle H, Neuhaus P.

Drugs. 2007;67(16):2293-310. Review.

PMID:
17983252
11.

Chemotherapy for pancreatic cancer.

Morris SL, Beasley M, Leslie M.

N Engl J Med. 2004 Jun 24;350(26):2713-5; author reply 2713-5. No abstract available.

12.

Radiotherapy in the adjuvant management of pancreatic adenocarcinoma.

Abrams RA.

Semin Oncol. 2005 Dec;32(6 Suppl 9):S30-2. Review.

PMID:
16399427
13.

The case for routine use of adjuvant therapy in pancreatic cancer.

Kennedy EP, Yeo CJ.

J Surg Oncol. 2007 Jun 1;95(7):597-603. Review.

PMID:
17230543
14.

Clinical evidence does not support the use of adjuvant radiotherapy in pancreatic cancer.

Neoptolemos JP.

Nat Clin Pract Oncol. 2008 Aug;5(8):431. doi: 10.1038/ncponc1188. No abstract available.

PMID:
18668027
15.

Functional evaluation of the human pancreas before and in the early period after hyperfractionated accelerated radiochemotherapy.

Horst E, Seidel M, Micke O, Rübe C, Schäfer U, Willich N.

Front Radiat Ther Oncol. 2002;37:17-25. No abstract available.

PMID:
11764659
16.

Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer.

Koong AC, Christofferson E, Le QT, Goodman KA, Ho A, Kuo T, Ford JM, Fisher GA, Greco R, Norton J, Yang GP.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):320-3.

PMID:
16168826
17.

Is adjuvant 5-FU-based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial? A meta-analysis of an unanswered question.

Khanna A, Walker GR, Livingstone AS, Arheart KL, Rocha-Lima C, Koniaris LG.

J Gastrointest Surg. 2006 May;10(5):689-97.

PMID:
16713541
18.

Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis.

Valentini V, Morganti AG, Macchia G, Mantini G, Mattiucci GC, Brizi MG, Alfieri S, Bossola M, Pacelli F, Sofo L, Doglietto G, Cellini N.

Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1094-9. doi: 10.1016/j.ijrobp.2007.07.2346.

PMID:
18313525
19.

Effectiveness of 5-fluorouracil treatment for actinic keratosis--a systematic review of randomized controlled trials.

Askew DA, Mickan SM, Soyer HP, Wilkinson D.

Int J Dermatol. 2009 May;48(5):453-63. doi: 10.1111/j.1365-4632.2009.04045.x. Review. No abstract available.

PMID:
19416373
20.

Chemotherapy for pancreatic cancer.

Tsai JY, Nadeem A, Safran H.

Med Health R I. 2004 May;87(5):132-4. No abstract available.

PMID:
15250609

Supplemental Content

Support Center